Related Experiment Videos
Papillary and follicular thyroid cancer: selective therapy
Comprehensive Therapy
|May 1, 1981
Summary
Papillary and follicular thyroid cancers generally have good outcomes. Aggressive treatment with thyroidectomy and radioactive iodine (131I) ablation improves survival for invasive or metastatic cases, especially in older patients.
Area of Science:
- Endocrinology
- Oncology
Background:
- Papillary and follicular thyroid cancers typically have excellent prognoses.
- However, some patients experience metastatic or invasive tumors, leading to mortality.
- Older patients (>40 years) often present with less favorable prognoses and require aggressive management.
Purpose of the Study:
- To outline optimal treatment strategies for papillary and follicular thyroid cancers.
- To identify factors influencing prognosis and guide therapeutic decisions.
Main Methods:
- Surgical management including total or near-total thyroidectomy.
- Radioactive iodine (131I) ablation for remaining thyroid tissue.
- Lymph node excision.
- Thyroid-stimulating hormone (TSH) suppression therapy.
Main Results:
- Most patients achieve excellent survival rates.
- Tumors larger than 1.5 cm, bilateral, metastatic, or locally invasive, and most follicular cancers necessitate aggressive treatment.
- Survival is significantly improved in cases of locally invasive or metastatic disease when the tumor concentrates 131I and residual tumor is ablated.
Conclusions:
- Aggressive surgical and radioiodine treatment strategies are crucial for managing advanced thyroid cancers.
- TSH suppression is a standard therapeutic component.
- Favorable outcomes are achievable even in complex cases with appropriate intervention.